- Home
- WATT vs EVGN Comparison
WATT vs EVGN Comparison
Compare WATT & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- EVGN
- Stock Information
- Founded
- WATT 2012
- EVGN 1999
- Country
- WATT United States
- EVGN Israel
- Employees
- WATT N/A
- EVGN N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- EVGN Agricultural Chemicals
- Sector
- WATT Technology
- EVGN Industrials
- Exchange
- WATT Nasdaq
- EVGN Nasdaq
- Market Cap
- WATT 9.1M
- EVGN 9.7M
- IPO Year
- WATT 2014
- EVGN N/A
- Fundamental
- Price
- WATT $0.42
- EVGN $1.42
- Analyst Decision
- WATT Strong Buy
- EVGN Strong Buy
- Analyst Count
- WATT 2
- EVGN 1
- Target Price
- WATT $2.25
- EVGN $12.00
- AVG Volume (30 Days)
- WATT 929.8K
- EVGN 21.1K
- Earning Date
- WATT 03-27-2025
- EVGN 03-06-2025
- Dividend Yield
- WATT N/A
- EVGN N/A
- EPS Growth
- WATT N/A
- EVGN N/A
- EPS
- WATT N/A
- EVGN N/A
- Revenue
- WATT $431,184.00
- EVGN $7,478,000.00
- Revenue This Year
- WATT $95.75
- EVGN $90.35
- Revenue Next Year
- WATT $834.07
- EVGN $38.71
- P/E Ratio
- WATT N/A
- EVGN N/A
- Revenue Growth
- WATT N/A
- EVGN 30.69
- 52 Week Low
- WATT $0.28
- EVGN $1.20
- 52 Week High
- WATT $2.70
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- WATT 44.73
- EVGN 42.28
- Support Level
- WATT $0.42
- EVGN $1.44
- Resistance Level
- WATT $0.49
- EVGN $1.55
- Average True Range (ATR)
- WATT 0.04
- EVGN 0.09
- MACD
- WATT 0.00
- EVGN -0.01
- Stochastic Oscillator
- WATT 29.60
- EVGN 17.41
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.